{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:18:29Z","timestamp":1744258709282,"version":"3.40.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005928","name":"Daiwa Securities Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011746","name":"NOVARTIS Foundation (Japan) for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011746","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-022-00715-0","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T14:02:46Z","timestamp":1656079366000},"page":"32-38","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fanconi syndrome in an elderly patient with membranous nephropathy during treatment with the immunosuppressant mizoribine"],"prefix":"10.1007","volume":"12","author":[{"given":"Sho","family":"Nishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7572-5004","authenticated-orcid":false,"given":"Naoki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudai","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayu","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Shimamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayumi","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Nishimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamiko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kasuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Naiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Iwano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"issue":"5","key":"715_CR1","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.2215\/CJN.02880608","volume":"3","author":"R Kleta","year":"2008","unstructured":"Kleta R. Fanconi or not Fanconi? Lowe syndrome revisited. Clin J Am Soc Nephrol. 2008;3(5):1244\u20135. https:\/\/doi.org\/10.2215\/CJN.02880608.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"715_CR2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/rheumatology\/kev223","volume":"54","author":"R Evans","year":"2015","unstructured":"Evans R, Zdebik A, Ciurtin C, Walsh SB. Renal involvement in primary Sjogren\u2019s syndrome. Rheumatol (Oxf). 2015;54(9):1541\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/kev223.","journal-title":"Rheumatol (Oxf)"},{"issue":"2","key":"715_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/nrneph.2015.174","volume":"12","author":"H Francois","year":"2016","unstructured":"Francois H, Mariette X. Renal involvement in primary Sjogren syndrome. Nat Rev Nephrol. 2016;12(2):82\u201393. https:\/\/doi.org\/10.1038\/nrneph.2015.174.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"715_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0889-8588(05)70126-X","volume":"13","author":"MQ Lacy","year":"1999","unstructured":"Lacy MQ, Gertz MA. Acquired Fanconi\u2019s syndrome associated with monoclonal gammopathies. Hematol Oncol Clin North Am. 1999;13(6):1273\u201380.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"715_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","volume":"15","author":"N Leung","year":"2019","unstructured":"Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D\u2019Agati VD, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2019;15(1):45\u201359. https:\/\/doi.org\/10.1038\/s41581-018-0077-4.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"715_CR6","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1562\/2005-05-29-RA-552","volume":"81","author":"S Winch","year":"2005","unstructured":"Winch S, Lean D. Comparison of changes in metal toxicity following exposure of water with high dissolved organic carbon content to solar UV-B and UV-A Radiation. Photochem Photobiol. 2005;81(6):1469\u201380. https:\/\/doi.org\/10.1562\/2005-05-29-RA-552.","journal-title":"Photochem Photobiol"},{"issue":"4","key":"715_CR7","doi-asserted-by":"publisher","first-page":"p105","DOI":"10.1159\/000083981","volume":"99","author":"O Barbier","year":"2005","unstructured":"Barbier O, Jacquillet G, Tauc M, Cougnon M, Poujeol P. Effect of heavy metals on, and handling by, the kidney. Nephron Physiol. 2005;99(4):p105\u201310. https:\/\/doi.org\/10.1159\/000083981.","journal-title":"Nephron Physiol"},{"issue":"1","key":"715_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/j.ajkd.2004.02.009","volume":"44","author":"C Isnard Bagnis","year":"2004","unstructured":"Isnard Bagnis C, Deray G, Baumelou A, Le Quintrec M, Vanherweghem JL. Herbs and the kidney. Am J Kidney Dis. 2004;44(1):1\u201311.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"715_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1053\/ajkd.2003.50037","volume":"41","author":"H Izzedine","year":"2003","unstructured":"Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G. Drug-induced Fanconi\u2019s syndrome. Am J Kidney Dis. 2003;41(2):292\u2013309. https:\/\/doi.org\/10.1053\/ajkd.2003.50037.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"715_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/qjmed\/hct258","volume":"107","author":"AM Hall","year":"2014","unstructured":"Hall AM, Bass P, Unwin RJ. Drug-induced renal Fanconi syndrome. QJM. 2014;107(4):261\u20139. https:\/\/doi.org\/10.1093\/qjmed\/hct258.","journal-title":"QJM"},{"issue":"9","key":"715_CR11","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2215\/CJN.01430219","volume":"14","author":"AM Hall","year":"2019","unstructured":"Hall AM, Unwin RJ. A case of drug-induced proximal tubular dysfunction. Clin J Am Soc Nephrol. 2019;14(9):1384\u20137. https:\/\/doi.org\/10.2215\/CJN.01430219.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"715_CR12","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1053\/j.ajkd.2017.06.021","volume":"70","author":"D Perrone","year":"2017","unstructured":"Perrone D, Afridi F, King-Morris K, Komarla A, Kar P. Proximal renal tubular acidosis (Fanconi Syndrome) induced by apremilast: a case report. Am J Kidney Dis. 2017;70(5):729\u201331. https:\/\/doi.org\/10.1053\/j.ajkd.2017.06.021.","journal-title":"Am J Kidney Dis"},{"key":"715_CR13","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.biopha.2018.08.050","volume":"107","author":"R Heidari","year":"2018","unstructured":"Heidari R, Ahmadi A, Mohammadi H, Ommati MM, Azarpira N, Niknahad H. Mitochondrial dysfunction and oxidative stress are involved in the mechanism of methotrexate-induced renal injury and electrolytes imbalance. Biomed Pharmacother. 2018;107:834\u201340. https:\/\/doi.org\/10.1016\/j.biopha.2018.08.050.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"715_CR14","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.kint.2020.07.019","volume":"98","author":"A Werion","year":"2020","unstructured":"Werion A, Belkhir L, Perrot M, Schmit G, Aydin S, Chen Z, et al. SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule. Kidney Int. 2020;98(5):1296\u2013307. https:\/\/doi.org\/10.1016\/j.kint.2020.07.019.","journal-title":"Kidney Int"},{"issue":"3","key":"715_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/ckj\/sfaa109","volume":"13","author":"R Kormann","year":"2020","unstructured":"Kormann R, Jacquot A, Alla A, Corbel A, Koszutski M, Voirin P, et al. Coronavirus disease 2019: acute Fanconi syndrome precedes acute kidney injury. Clin Kidney J. 2020;13(3):362\u201370. https:\/\/doi.org\/10.1093\/ckj\/sfaa109.","journal-title":"Clin Kidney J"},{"issue":"12","key":"715_CR16","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1681\/ASN.2016101074","volume":"28","author":"N Takahashi","year":"2017","unstructured":"Takahashi N, Saeki T, Komatsuda A, Munemura C, Fukui T, Imai N, et al. Tubulointerstitial nephritis with IgM-Positive plasma cells. J Am Soc Nephrol. 2017;28(12):3688\u201398. https:\/\/doi.org\/10.1681\/ASN.2016101074.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"715_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2174\/092986730607220401123549","volume":"6","author":"H Ishikawa","year":"1999","unstructured":"Ishikawa H. Mizoribine and mycophenolate mofetil. Curr Med Chem. 1999;6(7):575\u201397.","journal-title":"Curr Med Chem"},{"issue":"20","key":"715_CR18","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.2169\/internalmedicine.49.3810","volume":"49","author":"K Ichinose","year":"2010","unstructured":"Ichinose K, Origuchi T, Kawashiri SY, Iwamoto N, Fujikawa K, Aramaki T, et al. Efficacy and safety of mizoribine by one single dose administration for patients with rheumatoid arthritis. Intern Med. 2010;49(20):2211\u20138.","journal-title":"Intern Med"},{"issue":"2","key":"715_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10165-010-0373-8","volume":"21","author":"K Nishimura","year":"2011","unstructured":"Nishimura K, Nishino J, Kouchi A, Nakamura N, Nakajima S, Yokoe I, et al. Efficacy and safety of single-dose mizoribine for patients with rheumatoid arthritis: results at 6 months after switching from a multiple-dose regimen without a change in total daily dose. Mod Rheumatol. 2011;21(2):158\u201363. https:\/\/doi.org\/10.1007\/s10165-010-0373-8.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"715_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10165-012-0702-1","volume":"23","author":"H Yamanaka","year":"2013","unstructured":"Yamanaka H, Seto Y, Tanaka E, Furuya T, Nakajima A, Ikari K, et al. Management of rheumatoid arthritis: the 2012 perspective. Mod Rheumatol. 2013;23(1):1\u20137. https:\/\/doi.org\/10.1007\/s10165-012-0702-1.","journal-title":"Mod Rheumatol"},{"issue":"2","key":"715_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1328-8067.2001.01534.x","volume":"44","author":"Y Aihara","year":"2002","unstructured":"Aihara Y, Miyamae T, Ito S, Kobayashi S, Imagawa T, Mori M, et al. Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus. Pediatr Int. 2002;44(2):199\u2013204.","journal-title":"Pediatr Int"},{"issue":"13","key":"715_CR22","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1177\/0961203312458468","volume":"21","author":"A Nomura","year":"2012","unstructured":"Nomura A, Shimizu H, Kishimoto M, Suyama Y, Rokutanda R, Ohara Y, et al. Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis. Lupus. 2012;21(13):1444\u20139. https:\/\/doi.org\/10.1177\/0961203312458468.","journal-title":"Lupus"},{"issue":"1","key":"715_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1046\/j.1523-1755.2000.00168.x","volume":"58","author":"K Yoshioka","year":"2000","unstructured":"Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, Nakamura H, et al. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int. 2000;58(1):317\u201324. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00168.x.","journal-title":"Kidney Int"},{"issue":"2","key":"715_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10157-004-0276-0","volume":"8","author":"T Shibasaki","year":"2004","unstructured":"Shibasaki T, Koyama A, Hishida A, Muso E, Osawa G, Yamabe H, et al. A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey). Clin Exp Nephrol. 2004;8(2):117\u201326. https:\/\/doi.org\/10.1007\/s10157-004-0276-0.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"715_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1159\/000045438","volume":"83","author":"K Kaneko","year":"1999","unstructured":"Kaneko K, Nagaoka R, Ohtomo Y, Yamashiro Y. Mizoribine for childhood IgA nephropathy. Nephron. 1999;83(4):376\u20137. https:\/\/doi.org\/10.1159\/000045438.","journal-title":"Nephron"},{"issue":"7\u20138","key":"715_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.clinbiochem.2014.01.014","volume":"47","author":"S Xing","year":"2014","unstructured":"Xing S, Yang J, Zhang X, Zhou P. Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation\u2014a meta-analysis. Clin Biochem. 2014;47(7\u20138):663\u20139. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.01.014.","journal-title":"Clin Biochem"},{"issue":"1","key":"715_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11255-014-0850-7","volume":"47","author":"T Ito","year":"2015","unstructured":"Ito T, Mochizuki K, Oka T, Hanada K, Tanabe K. Study of mizoribine therapy in elderly patients with membranous nephropathy: comparison with patients not receiving mizoribine. Int Urol Nephrol. 2015;47(1):131\u20135. https:\/\/doi.org\/10.1007\/s11255-014-0850-7.","journal-title":"Int Urol Nephrol"},{"key":"715_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.lfs.2016.04.012","volume":"154","author":"X Wang","year":"2016","unstructured":"Wang X, Song X, Liu Y, Zhang W, An W, Tu Y. Treatment of membranous nephropathy with mizoribine: a control trial. Life Sci. 2016;154:75\u20138. https:\/\/doi.org\/10.1016\/j.lfs.2016.04.012.","journal-title":"Life Sci"},{"issue":"6","key":"715_CR29","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10157-016-1340-2","volume":"21","author":"T Saito","year":"2017","unstructured":"Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, et al. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome. Clin Exp Nephrol. 2017;21(6):961\u201370. https:\/\/doi.org\/10.1007\/s10157-016-1340-2.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"715_CR30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0022-3565(25)32239-1","volume":"214","author":"CF Simmons Jr","year":"1980","unstructured":"Simmons CF Jr, Bogusky RT, Humes HD. Inhibitory effects of gentamicin on renal mitochondrial oxidative phosphorylation. J Pharmacol Exp Ther. 1980;214(3):709\u201315.","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"715_CR31","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/ki.2010.318","volume":"78","author":"LC Herlitz","year":"2010","unstructured":"Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D\u2019Agati VD, Markowitz GS. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. Kidney Int. 2010;78(11):1171\u20137. https:\/\/doi.org\/10.1038\/ki.2010.318.","journal-title":"Kidney Int"},{"issue":"5","key":"715_CR32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.ajkd.2011.01.022","volume":"57","author":"AM Hall","year":"2011","unstructured":"Hall AM, Hendry BM, Nitsch D, Connolly JO. Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis. 2011;57(5):773\u201380. https:\/\/doi.org\/10.1053\/j.ajkd.2011.01.022.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"715_CR33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/MPH.0b013e3181f8cac0","volume":"33","author":"R Skinner","year":"2011","unstructured":"Skinner R. Nephrotoxicity\u2013what do we know and what don\u2019t we know? J Pediatr Hematol Oncol. 2011;33(2):128\u201334. https:\/\/doi.org\/10.1097\/MPH.0b013e3181f8cac0.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"15","key":"715_CR34","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.1158\/0008-5472.CAN-06-1043","volume":"66","author":"I Nissim","year":"2006","unstructured":"Nissim I, Horyn O, Daikhin Y, Nissim I, Luhovyy B, Phillips PC, et al. Ifosfamide-induced nephrotoxicity: mechanism and prevention. Cancer Res. 2006;66(15):7824\u201331. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1043.","journal-title":"Cancer Res"},{"issue":"7","key":"715_CR35","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.0013-9580.2004.05504.x","volume":"45","author":"M Knorr","year":"2004","unstructured":"Knorr M, Schaper J, Harjes M, Mayatepek E, Rosenbaum T. Fanconi syndrome caused by antiepileptic therapy with valproic Acid. Epilepsia. 2004;45(7):868\u201371. https:\/\/doi.org\/10.1111\/j.0013-9580.2004.05504.x.","journal-title":"Epilepsia"},{"key":"715_CR36","unstructured":"Murase J, Mizuno K, Kawai K, NIshiumi S, Kobayashi Y, Hayashi M et al. Absorption, distribution, metabolism, and excretion of bredinin in rats. Pharmacomet (Jpn). 1978;5(15):829\u201335."},{"issue":"11","key":"715_CR37","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/ard.59.11.841","volume":"59","author":"FC Breedveld","year":"2000","unstructured":"Breedveld FC, Dayer JM. Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis. 2000;59(11):841\u20139. https:\/\/doi.org\/10.1136\/ard.59.11.841.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"715_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/01.asn.0000040596.23073.01","volume":"14","author":"KJ Kelly","year":"2003","unstructured":"Kelly KJ, Plotkin Z, Vulgamott SL, Dagher PC. P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor. J Am Soc Nephrol. 2003;14(1):128\u201338. https:\/\/doi.org\/10.1097\/01.asn.0000040596.23073.01.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"715_CR39","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1523-1755.2004.761_7.x","volume":"66","author":"PC Dagher","year":"2004","unstructured":"Dagher PC. Apoptosis in ischemic renal injury: roles of GTP depletion and p53. Kidney Int. 2004;66(2):506\u20139. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.761_7.x.","journal-title":"Kidney Int"},{"issue":"3","key":"715_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.23876\/j.krcp.19.056","volume":"38","author":"I Kashoor","year":"2019","unstructured":"Kashoor I, Batlle D. Proximal renal tubular acidosis with and without Fanconi syndrome. Kidney Res Clin Pract. 2019;38(3):267\u201381. https:\/\/doi.org\/10.23876\/j.krcp.19.056.","journal-title":"Kidney Res Clin Pract"},{"issue":"5","key":"715_CR41","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.semnephrol.2006.07.001","volume":"26","author":"IA Bobulescu","year":"2006","unstructured":"Bobulescu IA, Moe OW. Na+\/H+ exchangers in renal regulation of acid-base balance. Semin Nephrol. 2006;26(5):334\u201344. https:\/\/doi.org\/10.1016\/j.semnephrol.2006.07.001.","journal-title":"Semin Nephrol"},{"issue":"4","key":"715_CR42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-201X.2004.01324.x","volume":"181","author":"C Aalkjaer","year":"2004","unstructured":"Aalkjaer C, Frische S, Leipziger J, Nielsen S, Praetorius J. Sodium coupled bicarbonate transporters in the kidney, an update. Acta Physiol Scand. 2004;181(4):505\u201312. https:\/\/doi.org\/10.1111\/j.1365-201X.2004.01324.x.","journal-title":"Acta Physiol Scand"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00715-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-022-00715-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00715-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:18:47Z","timestamp":1744201127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-022-00715-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["715"],"URL":"https:\/\/doi.org\/10.1007\/s13730-022-00715-0","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"assertion":[{"value":"31 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the Declaration of Helsinki of 1964 and its subsequent amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient described in this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}